VREX

$18.51-0.11%visit website

Varex Imaging Corp

Market Cap

$779M

Live price × SEC shares (Aug 3, 2026)

Sector

Health Care

Industry

Health Care

Beta (raw)

1.02

60mo monthly vs SPY

P/E (TTM)

34.9

TTM to Jul 2026 · diluted EPS

P/S (TTM)

0.9

TTM to Jul 2026 · revenue

P/B

1.6

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

10.8

TTM to Jul 2026 · EV incl. net debt

Flagged input, hover for details

Loading…

Financial Statements

USD thousands	Q4 FY2025 Oct 3, 2025	Q1 FY2026 Jan 2, 2026	Q2 FY2026 Apr 3, 2026	Q3 FY2026 Jul 3, 2026	TTM Jul 3, 2026
Revenue	228,900	209,600	216,000	210,500	865,000
Cost of revenue	151,100	139,800	143,400	133,800	568,100
Gross profit	77,800	69,800	72,600	76,700	296,900
Research & development	24,200	21,700	22,200	23,300	91,400
Selling, general & administrative	34,000	32,700	36,000	30,600	133,300
Total operating expenses	58,200	54,400	58,200	53,900	224,700
Operating income	19,600	15,400	14,400	22,800	72,200
Interest expense	7,900	7,900	17,200	5,800	38,800
Pretax income	14,100	3,800	(6,400)	16,200	27,700
Income tax	1,900	1,400	1,600	300	5,200
Net income	12,200	2,300	(8,100)	15,700	22,100
EPS (basic) ($)		0.06	(0.19)	0.37	0.54
EPS (diluted) ($)		0.05	(0.19)	0.37	0.53
Weighted avg. shares (basic)		41,800	42,000	42,100
Weighted avg. shares (diluted)		42,300	42,000	42,600

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 10, 2026, period ended Jul 3, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 39 more quarters, back to Jan 2016, with Tormere Pro.

Corporate Events (8-K)

2 filings in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 29, 2026 accepted 4:06 PM ET	8-K/A 5.07Shareholder vote	Document SEC ↗
Oct 29, 2026 accepted 9:11 AM ET	5.07Shareholder vote	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

19%

W/W -15.0pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

207.17x

Avg Daily Selling (90d)

1,535 sh/day

Baseline Daily Selling

18.4 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-14	2026-09-15	Kunkel Jay K.	Director	Sale	8,121	$18.48	$150K	15.3K	View
2026-09-11	2026-09-15	Maheshwari Shubham	Chief Financial Officer	Sale	130.0K	$18.46	$2.40M	140.0K	View
2026-03-20	2026-03-23	Kunkel Jay K.	Director	Sale	4,510	$11.14	$50K	23.4K	View